According to the approval letter, the license restricts the use of the vaccine called Nuvaxovid to individuals aged 65 and ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...